Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London
· Delayed Price · Currency is GBP · Price in USD 719.48
-3.82 (-0.53%)
Dec 5, 2025, 5:09 PM BST
Regeneron Pharmaceuticals Market Cap
Regeneron Pharmaceuticals has a market cap or net worth of 55.32 billion as of December 5, 2025. Its market cap has decreased by -12.48% in one year.
Market Cap
55.32B
Enterprise Value
43.29B
Revenue
10.60B
Ranking
n/a
PE Ratio
16.24
Stock Price
719.48
Market Cap Chart
Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 55.32B, an increase of 57,452.47%. That is a compound annual growth rate of 20.96%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.45B |
| Haleon | 32.02B |
| Smith & Nephew | 10.72B |
| Convatec Group | 4.49B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.73B |